Clinical Trial Update: Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial completed to evaluate the efficacy, safety, and tolerability of Iberogast for bowel troubles in patients with Parkinson's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IBEROGAST

Snippet

Sponsor: Nantes University Hospital | Conditions: Gastrointestinal Disorders in Parkinson's Disease | Phase 2 | Status: COMPLETED